Charity-minded share sale runs into an income math problem, with Medicare counting gains before deductions

A personal-finance post published by focuses on a scenario many investors consider “clean” from a tax and giving standpoint: sell appreciated shares, donate the cash to charity, and expect that the charitable contribution will offset the tax impact. The article argues that the Medicare side of the equation does not follow the same timing, because Medicare calculations can count the investment gain at a step that comes before the charitable deduction shows up on an individual’s tax paperwork.

The column centers on Berkshire Hathaway shares, using Berkshire Hathaway’s Class B stock as the example (ticker BRK.B). The core point is not about Berkshire’s business performance, but about how personal tax outcomes can affect eligibility and cost tiers tied to Medicare. In particular, it describes a situation where the sale generates a gain that increases reported income for purposes used to set certain Medicare premiums.

Under the logic described, the charitable contribution deduction may reduce taxable income, but it does not necessarily prevent the Medicare income measure from rising first. The practical result, as framed in the article title, is that the “gap” between when the gain is counted and when the charity deduction appears could mean the Medicare-related income threshold is still triggered, even though the donor ultimately contributed to charity.

The post’s framing implies that investors trying to be tax efficient by selling appreciated stock and then donating cash should not stop at their expected income tax math. Instead, it suggests that they need to consider how Medicare-related income calculations handle the timing of capital gains versus deductions, because the Medicare measure can be sensitive to the gross effect of a sale.

For readers, the takeaway is largely procedural: the charitable strategy can still be beneficial, but it may not “shield” Medicare premium calculations in the way some donors expect. That difference can matter most to people who are near Medicare premium thresholds used to determine higher-cost tiers, where a capital-gains year can move someone into a different payment level.

Berkshire Hathaway is used here as a familiar example of a stock that often has long holding periods, which can translate into sizable unrealized gains for older investors. While the investment itself is not the article’s focus, the example underscores how holding-period gains can create one-off spikes in income when liquidity is taken and funds are moved through a charitable plan.

The limitation is that the piece does not provide enough disclosed, primary documentation in the information available for this draft to pin down the exact tax forms, Medicare formula inputs, or any numeric threshold amounts. It also does not spell out alternative giving approaches (such as donating appreciated shares instead of donating cash) in a way that can be verified from the material referenced here.

Going forward, readers who are planning share sales in a year they expect to have Medicare exposure may want to treat the timing question as a checklist item. The next thing to watch is whether more detailed guidance emerges either in mainstream tax coverage or through Medicare and IRS resources that map the specific sequence of sale, reporting, and deductions used to calculate Medicare-related income measures.